What is the Share Price of Titan Biotech Ltd?

Titan Biotech Ltd share price is ₹441.00 As on 11 May, 2025|09:02

Home
>
Stocks
>
Titan Biotech Ltd

Titan Biotech Ltd Share Price

Q: What is the Market Cap of Titan Biotech Ltd?

The Market Cap of Titan Biotech Ltd is ₹365 As on 11 May, 2025|09:02

Q: What is PE Ratio of Titan Biotech Ltd?

The P/E ratio of Titan Biotech Ltd is 16.2 As on 11 May, 2025|09:02

Q: What is PB Ratio of Titan Biotech Ltd?

The PB ratio of Titan Biotech Ltd is 2.52 As on 11 May, 2025|09:02

₹ 0.00 0 (0%)
Updated on 01-01-1970 5:30 AM

Stock Rating

BSE

Pros 4

Cons 4

Titan Biotech Ltd Price Performance

Day's Low
₹0

Day's High
₹0

₹ 0

52-w low
₹0

52-w high
₹0

Day's open
₹0
Previous close
₹0
VWAP
₹0
Lower price band
₹0
Upper price band
₹0

Today's Market Action

Its last traded stock price on BSE was 441.00 down by -0.10%. The total volume of shares on NSE and BSE combined was 7,112 shares. Its total combined turnover was Rs 0.32 crores.

Titan Biotech Ltd Medium and Long Term Market Action

The stock price of Titan Biotech Ltd is down by -100% over the last one month. Don't forget to check the full stock price history in the table below.

Titan Biotech Ltd Fundamentals

Market Cap (Cr): 365
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Titan Biotech Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Titan Biotech Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Titan Biotech Ltd

Data not available.

Titan Biotech Ltd FAQ's

What is Share Price of Titan Biotech Ltd?

What is the Market Cap of Titan Biotech Ltd?

What is PE Ratio of Titan Biotech Ltd?

What is PB Ratio of Titan Biotech Ltd?

What is the CAGR of Titan Biotech Ltd?

How to Buy Titan Biotech Ltd Share?

Can I buy Titan Biotech Ltd from Samco?

How do I buy Titan Biotech Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Above Average Sustainable RoE
The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
High Pricing Power
The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.
Zero Debt
The company has almost nil to negligible debt to equity ratio of 0.02. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.
Above Average Growth Rate
The company is estimated to grow its earnings at a reasonable rate over the next few years which will drive shareholder value creation

Cons

Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 174 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
Poor Corporate Governance
The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(11/05/2025)

102

Margin of Safety Index: High

100.00%

100.00% People are bullish about Titan Biotech Ltd

0.00%

0.00 % People are bearish about Titan Biotech Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %